🚀 Enjoy a 7-Day Free Trial Thru Sep 23, 2024! ✨
Buffett Indicator U.S. Treasury Yield Curve
U.S. Inflation Rate Presidential Cycle and Stock MarketShiller P/E Shiller P/E by Sectors
GF Value for S&P 500 Index Fed Net Liquidity Latest IPOsTools
Guru Portfolio Download Insider Data Download Excel Add-In Google Sheets Add-On API Manual of Stocks DCF Calculator WACC Calculator Interactive Chart Maps Fund Letters Archive Stock Comparison Table Mobile App Discussion Board GuruAI Financial Calendar Embed Widgets Stock Market Holidays
Support
GURUFOCUS.COM Insider List Wayne P. Rothbaum
Wayne P. Rothbaum Net Worth
The estimated net worth of Wayne P. Rothbaum is at least $290 Million dollars as of 2024-09-16. Wayne P. Rothbaum is the Director of Iovance Biotherapeutics Inc and owns about 28,067,333 shares of Iovance Biotherapeutics Inc (IOVA) stock worth over $290 Million.Details can be seen in Wayne P. Rothbaum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wayne P. Rothbaum has not made any transactions after 2024-02-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...
Transaction Summary of Wayne P. Rothbaum
Wayne P. Rothbaum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wayne P. Rothbaum owns 1 companies in total, including Iovance Biotherapeutics Inc (IOVA).
Click here to see the complete history of Wayne P. Rothbaum’s form 4 insider trades.
Insider Ownership Summary of Wayne P. Rothbaum
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IOVA | Iovance Biotherapeutics Inc | 2024-02-20 | director |
Wayne P. Rothbaum Latest Holdings Summary
Wayne P. Rothbaum currently owns a total of 1 stock. Wayne P. Rothbaum owns 28,067,333 shares of Iovance Biotherapeutics Inc (IOVA) as of February 20, 2024, with a value of $290 Million.
Latest Holdings of Wayne P. Rothbaum
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IOVA | Iovance Biotherapeutics Inc | 2024-02-20 | 28,067,333 | 10.34 | 290,216,223 |
Holding Weightings of Wayne P. Rothbaum
Wayne P. Rothbaum Form 4 Trading Tracker
According to the SEC Form 4 filings, Wayne P. Rothbaum has made a total of4 transactions in Iovance Biotherapeutics Inc (IOVA) over the past 5 years, including 4 buys and 0 sells.The most-recent trade in Iovance Biotherapeutics Inc is theacquisitionof5,000,000 shares on February 20, 2024, whichcostWayne P. Rothbaum around $46 Million.
Insider Trading History of Wayne P. Rothbaum
No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
- 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.
Wayne P. Rothbaum Trading Performance
GuruFocus tracks the stock performance after each of Wayne P. Rothbaum's buying transactions within different timeframes.To be detailed, the average return of stocks after 3 months bought by Wayne P. Rothbaum is 22.27%.GuruFocus also compares Wayne P. Rothbaum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wayne P. Rothbaum within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wayne P. Rothbaum's insider trading performs compared to the benchmark.
Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.
Performance of Wayne P. Rothbaum
Average Return
Average return per transaction
Outperforming Transactions
3 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.39 | | | | | |
| Relative Return to S&P 500(%) | 15.64 | | | | | |
Wayne P. Rothbaum Ownership Network
Ownership Network List of Wayne P. Rothbaum
No Data
Ownership Network Relation of Wayne P. Rothbaum
Wayne P. Rothbaum Owned Company Details
What does Iovance Biotherapeutics Inc do?
Who are the key executives at Iovance Biotherapeutics Inc?
Wayne P. Rothbaum is the director of Iovance Biotherapeutics Inc. Other key executives at Iovance Biotherapeutics Inc include General Counsel Frederick G Vogt,Chief Operating Officer Igor Bilinsky,andChief Financial Officer Jean-marc Bellemin.
Iovance Biotherapeutics Inc (IOVA) Insider Trades Summary
Over the past 18 months, Wayne P. Rothbaum made2 insider transaction in Iovance Biotherapeutics Inc (IOVA) with a net purchaseof 10,000,000. Other recent insider transactions involving Iovance Biotherapeutics Inc (IOVA) include a net purchaseof 260,000 shares made by Merrill A Mcpeak,
In summary, during the past 3 months, insiders sold 0 shares of Iovance Biotherapeutics Inc (IOVA) in total and bought 0 shares, with a net saleof 0 shares. During the past 18 months, 0 shares of Iovance Biotherapeutics Inc (IOVA) were sold and 10,260,000 shares were bought by its insiders, resulting in a net purchaseof 10,260,000 shares.
Iovance Biotherapeutics Inc (IOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Iovance Biotherapeutics Inc Insider Transactions
No Available Data
Wayne P. Rothbaum Mailing Address
Above is the net worth, insider trading, and ownership report for Wayne P. Rothbaum. You might contact Wayne P. Rothbaum via mailing address: C/o Quogue Capital Llc, 1285 Avenue Of The Americas, 35th Floor, New York Ny 10019.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App ä¸æ–‡
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Follow Us
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circ*mstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.
